{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:57:06Z","timestamp":1787021826433,"version":"build-2736575974"},"update-to":[{"DOI":"10.1371\/journal.pntd.0010147","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T00:00:00Z","timestamp":1644883200000}}],"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T00:00:00Z","timestamp":1643846400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"national health and medical research council","doi-asserted-by":"publisher","award":["APP1127300"],"award-info":[{"award-number":["APP1127300"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:p>In 2019, the Murdoch Children\u2019s Research Institute in partnership with the Fiji Ministry of Health and Medical Services carried out an integrated mass drug administration (MDA) for the treatment of scabies and lymphatic filariasis in the Northern Division of Fiji (population estimate 131,914). We conducted a retrospective micro-costing exercise focused on the cost of scabies control in order to inform budgeting and policy decision making in an endemic setting. We collected detailed information on financial and economic costs incurred by both parties during the course of the MDA campaign (April 2018 to July 2019). We also conducted interviews with personnel involved in the financial administration of the MDA campaign. The economic cost of delivering two doses of ivermectin was US$4.88 per person. The cost of donated drugs accounted for 36.3% of total MDA costs. In this first large-scale MDA for the public health control of scabies, the estimated cost of delivering MDA per person for scabies was considerably more expensive than the costs reported for other neglected tropical diseases. The important cost drivers included the remuneration of health care workers who were extensively involved in the campaign, coverage of hard-to-reach, mainly rural populations and the two-dose regimen of ivermectin. These results highlight the importance of these cost determinants and can be used to plan current and future MDA programs.<\/jats:p>","DOI":"10.1371\/journal.pntd.0010147","type":"journal-article","created":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T13:55:33Z","timestamp":1643896533000},"page":"e0010147","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["Costs of mass drug administration for scabies in Fiji"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7301-0160","authenticated-orcid":true,"given":"Maria","family":"Mow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6231-5265","authenticated-orcid":true,"given":"Li Jun","family":"Thean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Parnaby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5035-8076","authenticated-orcid":true,"given":"Jyotishna","family":"Mani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Rafai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aalisha","family":"Sahukhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Kama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3403-3623","authenticated-orcid":true,"given":"Meciusela","family":"Tuicakau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Kado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9038-5300","authenticated-orcid":true,"given":"Lucia","family":"Romani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4909-1287","authenticated-orcid":true,"given":"Daniel","family":"Engelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4509-4461","authenticated-orcid":true,"given":"Margot","family":"Whitfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Kaldor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7346-0196","authenticated-orcid":true,"given":"Andrew","family":"Steer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5599-2209","authenticated-orcid":true,"given":"Natalie","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,2,3]]},"reference":[{"issue":"12","key":"pntd.0010147.ref001","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S1473-3099(17)30483-8","article-title":"The global burden of scabies: a cross-sectional analysis from the Global Burden of Disease Study 2015","volume":"17","author":"C Karimkhani","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"pntd.0010147.ref002","doi-asserted-by":"crossref","first-page":"845","DOI":"10.4269\/ajtmh.16-0753","article-title":"The epidemiology of scabies and impetigo in relation to demographic and residential characteristics: Baseline findings from the Skin Health Intervention Fiji Trial","volume":"97","author":"L Romani","year":"2017","journal-title":"Am J Trop Med Hyg"},{"issue":"12","key":"pntd.0010147.ref003","doi-asserted-by":"crossref","first-page":"e0008902","DOI":"10.1371\/journal.pntd.0008902","article-title":"A scabies outbreak in the North East Region of Ghana: The necessity for prompt intervention","volume":"14","author":"YA Amoako","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"pntd.0010147.ref004","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1525-1470.2011.01680.x","article-title":"Acute morbidity associated with scabies and other ectoparasitoses rapidly improves after treatment with ivermectin","volume":"29","author":"C Worth","year":"2012","journal-title":"Pediatr Dermatol"},{"issue":"5","key":"pntd.0010147.ref005","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1086\/504365","article-title":"An outbreak of scabies in a long-term care facility: the role of misdiagnosis and the costs associated with control","volume":"27","author":"G de Beer","year":"2006","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"11","key":"pntd.0010147.ref006","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1017\/S0950268816000443","article-title":"Retrospective analysis of institutional scabies outbreaks from 1984 to 2013: lessons learned and moving forward","volume":"144","author":"KE Mounsey","year":"2016","journal-title":"Epidemiol Infect"},{"issue":"3","key":"pntd.0010147.ref007","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1365-4632.2011.05017.x","article-title":"Impaired quality of life in adults and children with scabies from an impoverished community in Brazil","volume":"51","author":"C Worth","year":"2012","journal-title":"Int J Dermatol"},{"issue":"3","key":"pntd.0010147.ref008","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003452","article-title":"Scabies and impetigo prevalence and risk factors in Fiji: a national survey","volume":"9","author":"L Romani","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0010147.ref009","unstructured":"World Health Organization. Ending the neglect to attain the Sustainable Development Goals\u2014A road map for neglected tropical diseases 2021\u20132030: World Health Organization; 2020 [https:\/\/www.who.int\/neglected_diseases\/Ending-the-neglect-to-attain-the-SDGs\u2014NTD-Roadmap.pdf?ua=1]."},{"key":"pntd.0010147.ref010","unstructured":"Murdoch Children\u2019s Research Institute. World Scabies Program [Internet] [https:\/\/www.worldscabiesprogram.org\/."},{"issue":"1645","key":"pntd.0010147.ref011","doi-asserted-by":"crossref","first-page":"20130434","DOI":"10.1098\/rstb.2013.0434","article-title":"The contribution of mass drug administration to global health: past, present and future","volume":"369","author":"JP Webster","year":"2014","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"pntd.0010147.ref012","unstructured":"World Health Organization. Kiribati eliminates lymphatic filariasis 2019 [https:\/\/www.who.int\/westernpacific\/news\/detail\/07-10-2019-kiribati-eliminates-lymphatic-filariasis#:~:text=These%20are%3A%20Cambodia%2C%20China%2C,Nam%2C%20and%20Wallis%20and%20Futuna.]."},{"issue":"24","key":"pntd.0010147.ref013","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1056\/NEJMoa1500987","article-title":"Mass drug administration for scabies control in a population with endemic disease","volume":"373","author":"L Romani","year":"2015","journal-title":"N Engl J Med"},{"issue":"10","key":"pntd.0010147.ref014","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004151","article-title":"Impact of an ivermectin mass drug administration on scabies prevalence in a remote Australian Aboriginal community","volume":"9","author":"TM Kearns","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"10","key":"pntd.0010147.ref015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001362","article-title":"The cost of antibiotic mass drug administration for trachoma control in a remote area of South Sudan","volume":"5","author":"JH Kolaczinski","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"pntd.0010147.ref016","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1186\/s13071-015-0885-3","article-title":"Cost and cost-effectiveness of soil-transmitted helminth treatment programmes: systematic review and research needs","volume":"8","author":"HC Turner","year":"2015","journal-title":"Parasit Vectors"},{"issue":"1","key":"pntd.0010147.ref017","first-page":"1","article-title":"Estimating the programmatic cost of targeted mass drug administration for malaria in Myanmar","volume":"21","author":"SS Kyaw","year":"2021","journal-title":"BMC public health"},{"issue":"12","key":"pntd.0010147.ref018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005037","article-title":"Benchmarking the cost per person of mass treatment for selected neglected tropical diseases: an approach based on literature review and meta-regression with web-based software application","volume":"10","author":"C Fitzpatrick","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0010147.ref019","unstructured":"World Health Organisation. Review of delivery cost data on mass drug administration for malaria. 2015."},{"key":"pntd.0010147.ref020","unstructured":"Fiji Bureau of Statistics. 2017 Population and Housing Census Release 2: Fiji Bureau of Statistics. 2018; [https:\/\/www.statsfiji.gov.fj\/index.php\/statistics\/population-censuses-and-surveys]."},{"key":"pntd.0010147.ref021","unstructured":"Fiji Ministry of Health and Medical Services. Northern Transmission Assessment Survey III. Internal Report. 2018."},{"key":"pntd.0010147.ref022","unstructured":"World Health Organization. Guideline\u2014Alternative mass drug administration regiments to eliminate lymphatic filariasis: World Health Organization; 2017 [https:\/\/www.who.int\/lymphatic_filariasis\/resources\/9789241550161\/en\/]."},{"issue":"7","key":"pntd.0010147.ref023","doi-asserted-by":"crossref","first-page":"e0007541","DOI":"10.1371\/journal.pntd.0007541","article-title":"Dosing pole recommendations for lymphatic filariasis elimination: A height-weight quantile regression modeling approach","volume":"13","author":"CW Goss","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0010147.ref024","article-title":"Reference case for estimating the costs of global health services and interventions","author":"A Vassall","year":"2017","journal-title":"Project Report. Global Health Cost Consortium"},{"key":"pntd.0010147.ref025","volume-title":"Cost-effectiveness in health and medicine","author":"MC Weinstein","year":"1996"},{"issue":"7 Suppl 1","key":"pntd.0010147.ref026","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1097\/MLR.0b013e31819bc064","article-title":"Micro-costing quantity data collection methods","volume":"47","author":"KD Frick","year":"2009","journal-title":"Med Care"},{"issue":"10","key":"pntd.0010147.ref027","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1007\/s40273-020-00942-2","article-title":"Perspective and costing in cost-effectiveness analysis, 1974\u20132018","volume":"38","author":"DD Kim","year":"2020","journal-title":"PharmacoEconomics"},{"issue":"5","key":"pntd.0010147.ref028","doi-asserted-by":"crossref","first-page":"826","DOI":"10.4269\/ajtmh.2011.10-0635","article-title":"Costs of integrated mass drug administration for neglected tropical diseases in Haiti","volume":"85","author":"AS Goldman","year":"2011","journal-title":"Am J Trop Med Hyg"},{"key":"pntd.0010147.ref029","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/bs.apar.2015.01.002","article-title":"Economic and financial evaluation of neglected tropical diseases","volume":"87","author":"BY Lee","year":"2015","journal-title":"Adv Parasitol"},{"key":"pntd.0010147.ref030","unstructured":"Reserve Bank of Fiji. 2020 Economic Reviews [https:\/\/www.rbf.gov.fj\/category\/economic-reviews\/."},{"issue":"9","key":"pntd.0010147.ref031","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.jval.2019.03.021","article-title":"Adjusting for inflation and currency changes within health economic studies","volume":"22","author":"HC Turner","year":"2019","journal-title":"Value Health"},{"key":"pntd.0010147.ref032","unstructured":"Mectizan Donation Program. 2019 Mectizan Donation Program Annual Highlights 2020 [https:\/\/mectizan.org\/wp-content\/uploads\/2020\/06\/MDP_AH19_051921.pdf."},{"issue":"1","key":"pntd.0010147.ref033","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/heapol\/czm041","article-title":"Cost and cost-effectiveness of nationwide school-based helminth control in Uganda: intra-country variation and effects of scaling-up","volume":"23","author":"S Brooker","year":"2008","journal-title":"Health Policy Plan"},{"issue":"10","key":"pntd.0010147.ref034","doi-asserted-by":"crossref","first-page":"e1326","DOI":"10.1371\/journal.pntd.0001326","article-title":"Schistosomiasis and soil-transmitted helminth control in Niger: cost effectiveness of school based and community distributed mass drug administration [corrected]","volume":"5","author":"J Leslie","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"pntd.0010147.ref035","first-page":"728","article-title":"Investment success in public health: an analysis of the cost-effectiveness and cost-benefit of the global programme to eliminate lymphatic filariasis","volume":"64","author":"HC Turner","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"9464","key":"pntd.0010147.ref036","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S0140-6736(05)71134-X","article-title":"Achieving the millennium development goals","volume":"365","author":"A Fenwick","year":"2005","journal-title":"The Lancet"},{"issue":"10","key":"pntd.0010147.ref037","doi-asserted-by":"crossref","first-page":"e1132","DOI":"10.1016\/S2214-109X(18)30397-8","article-title":"Feasibility and safety of mass drug coadministration with azithromycin and ivermectin for the control of neglected tropical diseases: a single-arm intervention trial","volume":"6","author":"L Romani","year":"2018","journal-title":"Lancet Glob Health"},{"key":"pntd.0010147.ref038","unstructured":"Fiji Ministry of Health and Medical Services. Lymphatic Filariasis: Fiji Ministry of Health and Medical Services. 2014; [http:\/\/www.health.gov.fj\/lymphatic-filariasis\/]."},{"issue":"1","key":"pntd.0010147.ref039","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1371\/journal.pntd.0000067","article-title":"National mass drug administration costs for lymphatic filariasis elimination","volume":"1","author":"AS Goldman","year":"2007","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0010147.ref040","article-title":"Cost-Effectiveness of Mass Treatment with Azithromycin for Reducing Child Mortality in Malawi: Secondary Analysis from the MORDOR Trial","author":"JD Hart","year":"2020","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"pntd.0010147.ref041","doi-asserted-by":"crossref","first-page":"888","DOI":"10.4269\/ajtmh.2005.73.888","article-title":"The Leogane, Haiti demonstration project: decreased microfilaremia and program costs after three years of mass drug administration","volume":"73","author":"MB de Rochars","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"pntd.0010147.ref042","unstructured":"World Health Organization. Investing to overcome the global impact of neglected tropical diseases: third WHO report on neglected tropical diseases: World Health Organization; 2015."},{"issue":"8","key":"pntd.0010147.ref043","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1179\/2047773211Y.0000000010","article-title":"Cost-effectiveness of triple drug administration (TDA) with praziquantel, ivermectin and albendazole for the prevention of neglected tropical diseases in Nigeria","volume":"105","author":"D Evans","year":"2011","journal-title":"Ann Trop Med Parasitol"},{"issue":"1","key":"pntd.0010147.ref044","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1093\/inthealth\/ihs010","article-title":"Neglected tropical diseases: comparison of the costs of integrated and vertical preventive chemotherapy treatment in Niger","volume":"5","author":"J Leslie","year":"2013","journal-title":"Int Health"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0010147","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T00:00:00Z","timestamp":1644883200000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0010147","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T14:02:59Z","timestamp":1644933779000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0010147"}},"subtitle":[],"editor":[{"given":"Hugo C.","family":"Turner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,2,3]]},"references-count":44,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,2,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0010147","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,3]]}}}